Julio DelgadoDido GreenVignesh GopalanJoana Briosa NevesSantanu MaityMark P BrewinJustin WormaldTara M MastracciRoss J ThomsonGabriele SpoletiniReza MotallebzadehAarash SalehBruno MirandaElisabeth RounisStephanie WilmoreTushar KotechaM LeCainHenry GoodfellowSara NapettiNeil ChanchlaniPeter ButlerM A FazalCelia HardingJohn G CoghlanFred WickhamCharlotte WilsonVictoria F MiariAthalia Rachel PyzerStephen PowisAmin OomatiaShadaab MumtazGeorge Yizhou TangCameron B GreenTristan J BarberA McCarthy
P108
Open Label Extension of 2 mg/kg Pegunigalsidase Alfa (PRX-102) Every 4 Weeks in Adult Fabry Disease Patients3D Virtual Models as an Adjunct to Preoperative Surgical PlanningStudy in Subjects With Light Chain (AL) AmyloidosisPhase 3 Study of Obeticholic Acid in Patients With Primary Biliary CirrhosisInternational Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA)Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)Role of Cardiac CT in Rapid Access Chest Pain Clinics (RADICAL)Gilead Sustained Virologic Response (SVR) RegistryThe Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk SubjectsThe Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk SubjectsA 52 Week Study To Assess The Use Of Bococizumab (PF-04950615; RN316) In Subjects With Heterozygous Familial HypercholesterolemiaStrategic Timing of Antiretroviral TreatmentCohort Study of Healthcare Workers Receiving Imvanex®Prednisolone in Early Diffuse Systemic SclerosisTAK-954 in Critically Ill Participants With Enteral Feeding Intolerance (EFI)Motivating Structured Walking Activity in Intermittent ClaudicationImmediate Management of the Patient With Rupture : Open Versus Endovascular RepairRandomized Phase-II Study of Nivolumab Plus Ipilimumab vs. Standard of Care in Untreated and Advanced Non-clear Cell RCCStudy to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor Plus Emtricitabine/Tenofovir Fixed-Dose Combination to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically SA Study of CMV Vaccine (HB-101) in Kidney Transplant PatientsA Study of INCMGA00012 in Metastatic Merkel Cell CarcinomaExtension Study of 1 mg/kg Pegunigalsidase Alfa in Patients With Fabry DiseaseSafety, Pharmacokinetics, Pharmacodynamics, and Efficacy of Migalastat in Pediatric Subjects (Aged 12 to <18 Years)Efficacy Study for Geko Device in VLU PatientsEPA for Metastasis Trial 2Carboplatin and Gemcitabine Hydrochloride With or Without Vandetanib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urinary Tract CancerProspective, Single-arm, Multi Centre Observations Ultimaster Des RegistrySeladelpar in Subjects With Primary Biliary Cholangitis (PBC)Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
P6153
Q40386451-55DB0C2E-AE84-4830-AFF7-75393390B3BDQ47907982-5A2646C7-46F8-4092-AEF9-322809148F6DQ52673674-4901B484-1944-497C-8F13-709922D70680Q52987559-7721B2F9-FAAF-4D23-AAA6-6D8DD6F1D1A2Q53850327-0C07B7C0-2CFE-4E66-BB03-8C462260DC29Q56192165-5D1BBF46-0C5C-427A-B9EB-5D12AF109420Q56281735-62F29E08-B94B-4EDA-B745-64331DCFAAA6Q56930913-09D97134-5652-4E40-8792-71A6A16ADCB6Q56936187-2A276E4B-DBBE-4DA7-9E6D-47A2B070959BQ57035080-5537124D-976C-4098-870C-F6F28CBEB7C4Q58305723-8AF88D0B-EA28-443B-BFF4-0DC6DA299BA4Q58349965-6993F36F-4E76-459B-9269-85B38AFDFEFCQ58431555-BC936AD7-05FA-40CB-AB6C-AD9FE724B6A1Q60040866-19A30E33-4CA6-4CE8-8EC7-8D0B38275344Q60040866-28213780-8831-4ADF-9BED-6FCC814D67E6Q61054520-0B276AB2-C078-47D7-AD7E-C16900F91A8CQ61054520-277008B7-0FA1-4598-A2F7-722238325773Q61054520-812D9246-1D90-4AAD-97A8-354517E62D90Q61054520-8510E62B-98C5-4904-B92A-2ADECC22003CQ61054520-88F2E304-EDDA-420B-9977-7E982B0365FAQ61054520-A393D301-C801-4E24-A0B0-617D527D455FQ61054520-E20B92DC-82A9-4499-BA85-91645C9A4842Q61658696-268E0E37-ABEB-4BB6-9EAE-0B85D9C6E002Q61658696-E7D06448-EA8A-4F6A-B1D9-7C3D73E7CE37Q62352060-0C251B88-71D4-4F79-9798-C51E4EA85631Q64681966-33173618-5747-4149-ADD0-86704C5FFD87Q64800380-02F9152E-CB82-4397-B911-96A685D92C0CQ64820065-0A651D20-8D55-4B3B-8651-26F57237B7C7Q7173102-9E6EDF58-228D-4238-8765-46B102320700Q74225130-A9B5427F-65AE-4101-B9DD-EDF99A5DB690Q80033212-B3CEAAE5-BF95-4C42-B435-64B200F13A22Q83171736-146C1059-3166-4755-8B0D-A1149D0682ADQ85376067-E9865529-D3F0-4A2F-A5C6-F628F8AD9DE2Q86482484-60DF1A8D-6668-4A75-B9FB-C9A4A3828ADCQ87169111-58AA2EB1-757F-4015-8CE0-F10512842E7EQ87169111-B4EF03E5-10AD-4A59-852D-2F522968A609Q87662129-84044BEB-7C16-4212-93AD-9B326FC71467Q88109503-741d6af0-4c6a-81ca-6f1f-b0c0b9081283Q88400877-11711AC7-EAEB-4009-8C8E-00C993237AFAQ88741340-CD169BC4-5E3C-42C7-A0B6-7CBCDACDB4A0
P108
description
NHS foundation trust
@en
hospital de Reinu Xuníu
@ast
rumah sakit di Britania Raya
@id
ziekenhuis in het Verenigd Koninkrijk
@nl
בית חולים בממלכה המאוחדת
@he
مستشفى
@ar
병원
@ko
name
Royal Free London NHS Foundation Trust
@en
type
label
Royal Free London NHS Foundation Trust
@en
altLabel
Royal Free Hampstead NHS Trust
@en
prefLabel
Royal Free London NHS Foundation Trust
@en
P355
P244
P6366
P131
P2002
RoyalFreeNHS
P2003
royalfreelondonnhs
P2013
RoyalFreeNHS
P213
0000 0001 0439 3380
P214
P2427
grid.437485.9
P244
nb2004308564
P4527
P6366
P6782
P7859
lccn-nb2004308564
lccn-nb2014026658
P8167
royal_free_hampstead_nhs_trust
royal_free_london_nhs_foundation_trust